U.S. stock futures showed a slight dip today, with Dow futures slipping by approximately 50 points on Monday.
Esperion Therapeutics, Inc. (ESPR) experienced a significant surge in pre-market trading following the U.S. FDA’s approval of expanded labels for NEXLETOL® and NEXLIZET® for heart attack prevention.
Shares of Esperion Therapeutics soared by 12.7% to $2.58 in pre-market activity.
Other notable stocks making gains today include:
- Forge Global Holdings, Inc. (FRGE) saw a 22.8% increase to $2.86 in pre-market trading.
- Canopy Growth Corporation (CGC) rose by 19.5% to $9.17 in pre-market activity following German legislation legalizing cannabis possession and cultivation.
- Masimo Corporation (MASI) climbed 13.8% to $153.65 in pre-market trading after announcing a potential separation of its consumer business and reaffirming guidance for Q1 and FY24.
- Cronos Group Inc. (CRON) rose 9.6% to $2.86 in pre-market activities.
- Nuvation Bio Inc. (NUVB) gained 8.2% to $2.50 in pre-market trading.
- Tilray Brands, Inc. (TLRY) jumped 5.2% to $2.43 in pre-market trading after Germany’s approval for adult cannabis use.
- WK Kellogg Co (KLG) experienced a 4.8% increase to $19.49 in pre-market trading.
- GoodRx Holdings, Inc. (GDRX) shares climbed 4.1% to $6.85 in pre-market trading, driven by an upgrade from Wells Fargo analyst Stan Berenshteyn.
- Century Aluminum Company (CENX) shares gained 3.6% to $13.69 in pre-market activity.
Looking at an overall positive market sentiment, with various stocks showing promising movements even in pre-market conditions.
Now Read This: Investor Optimism Improves Slightly; Dow Jumps Over 250 Points
Don’t forget to check out our premarket coverage for more insights.
